Still a bit of resistance and sellers depth pre 1.10, but I think the storm has passed and post EOFY MYX will begin to realise its true value. One or two institutional investor followed with a Director's buy will see this fly back to 1.6-1.7 quickly.
Ann: FDA approval and first generic launch of Acticlate tablets, page-30
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.78 |
Change
-0.030(0.62%) |
Mkt cap ! $406.6M | |||
| Open | High | Low | Value | Volume |
| $4.84 | $4.84 | $4.63 | $435.1K | 91.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 746 | $4.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.78 | 1776 | 2 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| MYX (ASX) Chart |